Pillstats
Rx only · Kit

Temsirolimus

Brands: Torisel

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)657797
US makers2 labelers
Packages2
DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Accord Healthcare Inc.unknown1SUPPLYING
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 10, 2014
    RECALLRecall (Class III): TORISEL Kit (temsirolimus) injection, 25 mg/mL, 1 vial of TORISEL 25 mg/mL and 1 vial of 2.2 mL DILUENT per carton, Rx …

    Crystallization: Impurities in a raw material used to manufacture the diluent can cause the formation of crystals in the diluent vials after cold storage. The TORISEL vials are not affected by this issue. — Recalling firm: Pfizer Inc. — Nationwide and Puerto Rico

  • Nov 26, 2012
    RECALLRecall (Class III): TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a carton containing 1 vial TORISEL …

    Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials. — Recalling firm: Pfizer Inc. — Nationwide